Novel Targets Aim to Expand the Treatment Landscape of Metastatic Prostate Cancer

December 01, 2024

Videos

Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC

AKT Inhibitors – Targeting PI3K/AKT/MTOR Signaling Axis

Cora Sternberg, MD

VIEW VIDEO

Broadening Treatment Horizons with CDK4/6 Inhibitors from Breast to Prostate Cancer

Rana R. McKay, MD

VIEW VIDEO

Unlocking Precision Care: Germline & Somatic Literacy in Prostate Cancer

Elisabeth I. Heath, MD, FACP

VIEW VIDEO

PARP Inhibitors: Targeting DNA Repair Pathways

Neal Shore, MD, FACS

VIEW VIDEO

Unlocking the Future of mCRPC Treatment: Exploring Immune Checkpoint Inhibitors for MMR Loss and MSI-High

Sumit K. Subudhi, MD, PhD

VIEW VIDEO

The Current Treatment Landscape in Metastatic Hormone-Sensitive Prostate Cancer

Andrew Armstrong, MD

VIEW VIDEO

CONNECT WITH US

Questions or Comments? Email us at

Digital Science Press, LLC
2011 Phaethon Lane
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.